Episode 259: Journal Club Discussion of COVID-19 Practice Responsiveness, Systemic Adverse Events with Anti-VEGF and More

Drs. Priya Vakharia, Shriji Patel, and Yoshihiro Yonekawa join for a journal club discussing four recent publications in major ophthalmology journals:

• Practice Patterns During COVID-19
• Systemic Adverse Events with Anti-VEGF Therapy
• Predatory Publishing in Ophthalmology
• Caring for VIPs in Ophthalmology

Relevant Financial Disclosures: Dr. Sridhar is a consultant for Regeneron. Dr. Yonekawa is a consultant for Allergan. Drs. Vakharia and Patel have no financial disclosure.

CME Information

Release: September 28, 2020; expires September 28, 2023

Reviewers: Purnima Patel, MD; Shriji Patel, MD; Carl Danzig, MD

Disclosures: The physician reviewers and Academy staff report no relevant financial disclosures.

Learning Objective: Upon completion of this episode, the listener should be able to describe evolving standards of care for the management of vitreoretinal disorders or the outcomes from recent research and how these impact patient care decisions.

Audience: This activity is intended for retina subspecialists and comprehensive ophthalmologists.

Accreditation: The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Academy of Ophthalmology designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits.^TM Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hardware/Software Requirements: This learning activity requires a current web browser and speaker or headset capable of playing streaming audio.